Lung cancer Posts on Medivizor
Navigation Menu

Lung cancer Posts on Medivizor

Long-term effects of stereotactic ablative radiotherapy for patients with NSCLC

Posted by on May 2, 2017 in Lung cancer | 0 comments

In a nutshell The authors examined the long-term effects of stereotactic ablative radiotherapy (SABR) in treating patients with stage 1 non-small-cell lung cancer (NSCLC). They concluded that SABR is both safe and effective in the long-term. Some background SABR is a type of radiation used to treat inoperable early stage NSCLC. Studies have shown...

Read More

Osimertinib is effective in pretreated non-small cell lung cancer with EGFR-T790M mutations

Posted by on May 1, 2017 in Lung cancer | 0 comments

In a nutshell This trial examined the effectiveness and safety of osimertinib (Tagrisso) for treating patients with advanced non-small cell lung cancers that harbor T790M mutations. The authors concluded that the drug is promising in both safety and effectiveness at treating this type of cancer. Some background Non-small cell lung cancers...

Read More

Altering drug dosage during chemotherapy can decrease toxic side effects for patients with NSCLC

Posted by on Apr 15, 2017 in Lung cancer | 0 comments

In a nutshell This trial examined whether altering the recommended dose of chemotherapy drugs during treatment was beneficial to patients. This trial concluded that altering doses of paclitaxel (Taxol) during chemotherapy could be beneficial to reduce neuropathy in patients with advanced non-small-cell lung cancer.      Some...

Read More

Surgery to treat stage 1 non-small cell lung cancer

Posted by on Apr 14, 2017 in Lung cancer | 0 comments

In a nutshell This trial examined different surgical techniques to treat early stage non-small-stage lung cancer. The authors concluded that there was no difference in effectiveness between three different surgical techniques for patients with early stage NSCLC.   Some background Early-stage non-small cell lung cancer (NSCLC) is commonly...

Read More

Using aggressive treatment after first line treatment for advanced non-small-cell lung cancer

Posted by on Feb 20, 2017 in Lung cancer | 0 comments

In a nutshell The authors examined the use of local consolidative therapy to treat patients with advanced NSCLC with few metastases after first line treatment. They concluded that this is more effective than maintenance therapy alone for this specific group of patients. Some background Previous studies that examined treatment failure after first...

Read More

Immunotherapy for previously treated NSCLC

Posted by on Jan 9, 2017 in Lung cancer | 0 comments

In a nutshell This trial examined whether the immunotherapy atezolizumab (Tecentriq) is more effective than docetaxel (Taxotere) at treating non-small-cell lung cancer that has progressed passed first line treatment. The authors concluded that atezolizumab provided an overall survival benefit compared to docetaxel. Some background Docetaxel is the...

Read More

Could immunotherapy be more beneficial than chemotherapy at treating some types of NSCLC?

Posted by on Dec 19, 2016 in Lung cancer | 0 comments

In a nutshell This trial determined whether pembrolizumab (Keytruda) is more effective at treating advanced NSCLC than chemotherapy in patients with high levels of a specific protein called PD-L1. The authors concluded that, for this subgroup of patients, pembrolizumab was more effective and safer than chemotherapy. Some background In some...

Read More

Treating non-small-cell lung cancer with immunotherapy

Posted by on Dec 18, 2016 in Lung cancer | 0 comments

In a nutshell This review focused on whether adoptive immunotherapy (AI) can positively influence the chance of survival for patients with non-small-cell lunger cancer (NSCLC) that have undergone surgery. The authors concluded that AI post surgery is safe and effective.  Some background For patients with NSCLC, surgery is usually followed by...

Read More